These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11549783)
1. History of quinolones and their side effects. Rubinstein E Chemotherapy; 2001; 47 Suppl 3():3-8; discussion 44-8. PubMed ID: 11549783 [TBL] [Abstract][Full Text] [Related]
2. Comparison of side effects of levofloxacin versus other fluoroquinolones. Carbon C Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784 [TBL] [Abstract][Full Text] [Related]
3. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
4. Latest industry information on the safety profile of levofloxacin in Japan. Yagawa K Chemotherapy; 2001; 47 Suppl 3():38-43; discussion 44-8. PubMed ID: 11549788 [TBL] [Abstract][Full Text] [Related]
5. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety. Goldstein EJ Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103 [TBL] [Abstract][Full Text] [Related]
6. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. Kim J; Ohtani H; Tsujimoto M; Sawada Y Drug Metab Pharmacokinet; 2009; 24(2):167-74. PubMed ID: 19430173 [TBL] [Abstract][Full Text] [Related]
7. The safety profile of the fluoroquinolones. Bertino J; Fish D Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507 [TBL] [Abstract][Full Text] [Related]
8. Safety of the new fluoroquinolones compared with ciprofloxacin. Ball P J Chemother; 2000 Jan; 12 Suppl 1():8-11. PubMed ID: 11414383 [TBL] [Abstract][Full Text] [Related]
9. Quinolone activity against anaerobes. Appelbaum PC Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708 [TBL] [Abstract][Full Text] [Related]
10. Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint. Lode H Chemotherapy; 2001; 47 Suppl 3():24-31; discussion 44-8. PubMed ID: 11549786 [TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Lipsky BA; Baker CA Clin Infect Dis; 1999 Feb; 28(2):352-64. PubMed ID: 10064255 [TBL] [Abstract][Full Text] [Related]
13. Safety profile of the fluoroquinolones: focus on levofloxacin. Liu HH Drug Saf; 2010 May; 33(5):353-69. PubMed ID: 20397737 [TBL] [Abstract][Full Text] [Related]